A Th2 immune shift to heat shock protein 65 fails to arrest atherosclerosis: Proatherogenic role of Th2-deviated autoantibodies

References

• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 3521685–1695.
   PubMed Web of Science ®Google Scholar
• Blasi C. The autoimmune origin of atherosclerosis. Atherosclerosis. 2008; 117–32.
   Google Scholar
• Pockley AG. Heat shock proteins, inflammation, and cardiovascular disease. Circulation. 2002; 1051012–1017.
   PubMed Web of Science ®Google Scholar
• Ford P, Gemmell E, Walker P, West M, Cullinan M, Seymour G. Characterization of heat shock protein-specific T cells in atherosclerosis. Clin Diagn Lab Immunol. 2005; 12259–267.
   PubMedGoogle Scholar
• Jones DB, Hunter NR, Duff GW. Heat-shock protein 65 as a beta cell antigen of insulin-dependent diabetes. Lancet. 1990; 336583–585.
   PubMed Web of Science ®Google Scholar
• Tong L, Moudgil KD. Celastrus aculeatus Merr. suppresses the induction and progression of autoimmune arthritis by modulating immune response to heat-shock protein 65. Arthritis Res Ther. 2007; 9R70.
   Web of Science ®Google Scholar
• Gao YL, Brosnan CF, Raine CS. Experimental autoimmune encephalomyelitis. Qualitative and semiquantitative differences in heat shock protein 60 expression in the central nervous system. J Immunol. 1995; 1543548–3556.
   PubMed Web of Science ®Google Scholar
• Frostegård J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999; 14533–43.
   PubMed Web of Science ®Google Scholar
• Benagiano M, Azzurri A, Ciervo A, Amedei A, Tamburini C, Ferrari M, Telford JL, Baldari CT, Romagnani S, Cassone A, D'Elios MM, Del Prete G. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci U S A. 2003; 1006658–6663.
   PubMed Web of Science ®Google Scholar
• Huurman VA, van der Meide PE, Duinkerken G, Willemen S, Cohen IR, Elias D, Roep BO. Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes. Clin Exp Immunol. 2008; 152488–497.
   PubMed Web of Science ®Google Scholar
• Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med. 1996; 1831561–1567.
   PubMed Web of Science ®Google Scholar
• Ruiz PJ, Garren H, Ruiz IU, Hirschberg DL, Nguyen LV, Karpuj MV, Cooper MT, Mitchell DJ, Fathman CG, Steinman L. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: Modulation of T-cell costimulation. J Immunol. 1999; 1623336–3341.
   PubMed Web of Science ®Google Scholar
• Im SH, Barchan D, Fuchs S, Souroujon MC. Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment. J Clin Invest. 1999; 1041723–1730.
   PubMed Web of Science ®Google Scholar
• Schett G, Xu Q, Amberger A, Van der Zee R, Recheis H, Willeit J, Wick G. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest. 1995; 962569–2577.
   PubMed Web of Science ®Google Scholar
• Xu Q, Schett G, Seitz CS, Hu Y, Gupta RS, Wick G. Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ Res. 1994; 751078–1085.
   PubMed Web of Science ®Google Scholar
• Foteinos G, Afzal AR, Mandal K, Jahangiri M, Xu Q. Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage. Circulation. 2005; 1121206–1213.
   PubMed Web of Science ®Google Scholar
• Schett G, Metzler B, Mayr M, Amberger A, Niederwieser D, Gupta RS, Mizzen L, Xu Q, Wick G. Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis. 1997; 12827–38.
   PubMed Web of Science ®Google Scholar
• Jin L, Wang Y, Xiong Q, Chen Q, Li J, Zhu A, Cao R, Wu J, Liu J. Long-lasting specific antibodies against P277 induced by mucosal administration of P277 repeat sequences carried by Hsp65 in the absence of adjuvants. Vaccine. 2007; 252043–2050.
   PubMed Web of Science ®Google Scholar
• Jin L, Zhu A, Wang Y, Chen Q, Xiong Q, Li J, Sun Y, Li T, Cao R, Wu J, Liu J. A Th1-recognized peptide P277, when repeated in tandem, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in non-obese diabetic mice. J Immunol. 2008; 18058–63.
   PubMed Web of Science ®Google Scholar
• Maron R, Sukhova G, Faria AM, Hoffmann E, Mach F, Libby P, Weiner HL. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation. 2002; 1061708–1715.
   PubMed Web of Science ®Google Scholar
• Quintana FJ, Rotem A, Carmi P, Cohen IR. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in non-obese diabetic mice: Modulation of spontaneous 60-kDa heat shock protein autoimmunity. J Immunol. 2000; 1656148–6155.
   PubMed Web of Science ®Google Scholar
• Bockova J, Elias D, Cohen IR. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies. J Autoimmun. 1997; 10323–329.
   PubMed Web of Science ®Google Scholar
• Lyons JA, Ramsbottom MJ, Cross AH. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur J Immunol. 2002; 321905–1913.
   PubMed Web of Science ®Google Scholar
• Pfister G, Stroh CM, Perschinka H, Kind M, Knoflach M, Hinterdorfer P, Wick G. Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. J Cell Sci. 2005; 1181587–1594.
   PubMed Web of Science ®Google Scholar
• Morris-Downes MM, Smith PA, Rundle JL, Piddlesden SJ, Baker D, Pham-Dinh D, Heijmans N, Amor S. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice. J Neuroimmunol. 2002; 125114–124.
   PubMed Web of Science ®Google Scholar
• Kidd P. Th1/Th2 balance: The hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003; 8223–246.
   PubMedGoogle Scholar
• Pedotti R, Mitchell D, Wedemeyer J, Karpuj M, Chabas D, Hattab EM, Tsai M, Galli SJ, Steinman L. An unexpected version of horror autotoxicus: Anaphylactic shock to a self-peptide. Nat Immunol. 2001; 2216–222.
   PubMed Web of Science ®Google Scholar
• Liu E, Moriyama H, Abiru N, Miao D, Yu L, Taylor RM, Finkelman FD, Eisenbarth GS. Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9–23 and B:13–23. J Clin Invest. 2002; 1101021–1027.
   PubMed Web of Science ®Google Scholar